Voyager Therapeutics (NASDAQ: VYGR) affiliate files to sell 9,406 shares
Rhea-AI Filing Summary
Voyager Therapeutics (VYGR) notice of proposed sale of 9,406 shares of common stock under Section 144, with the transaction dated 05/15/2026. The filing notes an option granted on 02/06/2026 and lists 60,421,287 shares outstanding as of 05/15/2026 as a context figure. The record shows a prior sale of 4,668 shares on 02/24/2026 generating $17,588.09 in proceeds.
Positive
- None.
Negative
- None.
Insights
Form 144 reports a proposed registered resale of shares by an affiliate under Rule 144.
The filing lists 9,406 shares proposed for sale on 05/15/2026, tied to an option granted 02/06/2026. It also records a prior disposition of 4,668 shares on 02/24/2026.
Rule 144 notices are administrative disclosures; the actual sale depends on broker execution and compliance with holding‑period and public information requirements. Subsequent filings will show completion or further dispositions.